Gordon W. Dewald

Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion

Alan F. List, Gordon W. Dewald, John M. Bennett et al. · New England Journal of Medicine · 2006 · 1.3K citations

Anthracycline Dose Intensification in Acute Myeloid Leukemia

Hugo F. Fernández, Zhuoxin Sun, Xiaopan Yao et al. · New England Journal of Medicine · 2009 · 900 citations · Full text

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

Anthony V. Moorman, Christine J. Harrison, Georgina Buck et al. · Blood · 2006 · 728 citations · Full text

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Rafaël Fonseca, Emily Blood, Montserrat Rué et al. · Blood · 2003 · 658 citations

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes

David P. Steensma, Gordon W. Dewald, Terra L. Lasho et al. · Blood · 2005 · 466 citations · Full text